QTTB

Q32 Bio Inc.

There isn't enough reported data to score QTTB yet.

QTTB Fundamentals

MetricStatus
Weak
Under pressure
Unavailable
Strong

QTTB's balance sheet is currently strong, but its revenue and profitability are under pressure. There isn't enough data to rate its cash flow.

QTTB PE Valuation

CHEAPFAIREXPENSIVE1.5x2.9x4.4x5.9x
CHEAPFAIREXPENSIVE1.5x2.9x4.4x5.9x
LevelPEPriceVs current
Cheap2.4x$8.37-5.2%
Current2.6x$8.82โ€”
Fair2.9x$10.05+14%
Expensive4.8x$16.68+89%

Historical ranges are pointers, not guarantees.

QTTB's PE is 2.5x, but its earnings don't support one, so it isn't a reliable read right now.

QTTB Forward outlook

There aren't enough analyst estimates for QTTB to show an outlook.

QTTB Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $8.82 on Nov 12.

There is not enough scenario data to assess QTTB's risk to reward.

QTTB Earnings Per Share

Q4 2023: $-35.10Q1 2024: $-32.43Q2 2024: $-22.87Q3 2024: $-14.07Q4 2025: $2.42Q1 2026: $2.78Q2 2026: $3.12Q3 2026: $3.46
Q4 2023: $-35.10Q1 2024: $-32.43Q2 2024: $-22.87Q3 2024: $-14.07Q4 2025: $2.42Q1 2026: $2.78Q2 2026: $3.12Q3 2026: $3.46
QuarterTTM EPSYoY
Q3 2024-$14.07+$26.61
Q2 2024-$22.87+$18.17
Q1 2024-$32.43+$6.81
Q4 2023-$35.10-$33.48
Q3 2023-$40.68-$38.16
Q2 2023-$41.04-$39.42
Q1 2023-$39.24-$37.08
Q4 2022-$1.62+$29.52

QTTB has returned to profit: it earned $3.46 per share over the past year, after losing money the year before.

QTTB Quarterly Revenue

Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
QuarterRevenueYoY
Q2 2023$354K-56%
Q1 2023$802K0%
Q4 2022$802K0%
Q3 2022$802K-52%
Q2 2022$802K-63%
Q1 2022$802K-97%
Q4 2021$802K-18%
Q3 2021$1.7M+196%

QTTB's revenue has slid since its 2021 peak: $0 last quarter.

QTTB Free Cash Flow

Q4 2023: โˆ’$22MQ1 2024: โˆ’$15MQ2 2024: โˆ’$22MQ3 2024: โˆ’$20MQ4 2024: โˆ’$11MQ1 2025: โˆ’$12MQ2 2025: --Q3 2025: โˆ’$4MQ4 2025: โˆ’$6MQ1 2026: โˆ’$6MQ2 2026: โˆ’$3MQ3 2026: --
Q4 2023: โˆ’$22MQ1 2024: โˆ’$15MQ2 2024: โˆ’$22MQ3 2024: โˆ’$20MQ4 2024: โˆ’$11MQ1 2025: โˆ’$12MQ2 2025: --Q3 2025: โˆ’$4MQ4 2025: โˆ’$6MQ1 2026: โˆ’$6MQ2 2026: โˆ’$3MQ3 2026: --
QuarterFree cash flowYoY
Q1 2026-$6.3M+$6.1M
Q4 2025-$6.2M+$5.3M
Q3 2025-$4.2M+$15.4M
Q1 2025-$12.5M+$2.1M
Q4 2024-$11.4M+$10.1M
Q3 2024-$19.6M+$5.4M
Q2 2024-$22.2M+$1.4M
Q1 2024-$14.6M+$11.7M

QTTB has burned cash in almost every quarter: โˆ’$20M over the past year, against โˆ’$66M the year before.

QTTB Total Shares

Q4 2023: 3MQ1 2024: 2MQ2 2024: 12MQ3 2024: 12MQ1 2025: 12MQ2 2025: 12MQ3 2025: 12MQ4 2025: 12MQ1 2026: 14MQ2 2026: 20MQ3 2026: 34M
Q4 2023: 3MQ1 2024: 2MQ2 2024: 12MQ3 2024: 12MQ1 2025: 12MQ2 2025: 12MQ3 2025: 12MQ4 2025: 12MQ1 2026: 14MQ2 2026: 20MQ3 2026: 34M
PeriodChange %Net change
Quarterly+67%+13.7M shares
1 year+178%+21.8M shares
3 years+960%+30.8M shares
5 years+984%+30.9M shares
Available history+1354%+31.7M shares

QTTB has 34M diluted shares, up 178% from a year ago.

QTTB Net Leverage

Q4 2025: -2.2xQ1 2026: -2.0xQ2 2026: -4.9xQ3 2026: -15.4x
Q4 2025: -2.2xQ1 2026: -2.0xQ2 2026: -4.9xQ3 2026: -15.4x
QuarterNet LeverageStatus
Q3 2026-15.4xNet Cash
Q2 2026-4.9xNet Cash
Q1 2026-2.0xNet Cash
Q4 2025-2.2xNet Cash

QTTB has more cash than debt.

QTTB Weekly Momentum

MetricValueStatus
RSI45.1Neutral
Stochastic17.7Oversold

QTTB's weekly RSI is 45 (neutral) and its Stochastic is 18 (oversold).

QTTB PE vs Healthcare Sector

MetricQTTBSector medianRelative
PE2.6x26x90% below
PE %20299 pts below

QTTB is trading at 2.5x earnings, a 90% discount to the Healthcare sector's median of 26x, though its earnings don't support one.

QTTB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$8.563% above
20 week MA$11.725% below
50 week MA$8.316.1% above
100 week MA$5.2967% above
200 week MA$14.338% below

QTTB's trend is mixed: it's above three of its five weekly moving averages, and 38% below its 200-week average.

QTTB Yearly ROI

YearStart priceEnd priceROI
2020$388.6$227.7-41%
2021$227.7$74.5-67%
2022$74.5$21.4-71%
2023$21.4$10.9-49%
2024$10.9$3.36-69%
2025$3.36$3.20-4.8%
2026 YTD$3.20$8.82+176%

QTTB has finished every year since 2020 lower, and it's up 176% so far in 2026.

Give your agent the market.

Get API key